Skip to content
Dose Brief
Menu

Harper Meds Review — Current Status and Historical Score

By Updated

Harper Meds announced a move to Blue Haven Rx with an October 31 account deadline; current Harper enrollment and existing-patient continuity need confirmation.

Historical Brief Score70/100Recorded grade CDirectory position by recorded score: 165
View Harper Meds status View current availability and member information.

On the record

The FDA issued a warning letter to Nexus Health Solutions LLC dba Harper Meds in June 2026. Read the letter in the FDA's warning letter database for the agency's findings.

Semaglutide

Current Harper quote unconfirmed

Earlier $149/mo observation is historical. Harper announced a Blue Haven migration; confirm current service and new payment terms.

Full price details

Current Harper-branded service and medication quote unknown after the announced migration; earlier listing: $149/mo

Tirzepatide

Current Harper quote unconfirmed

Earlier $196/mo observation is historical. Harper announced a Blue Haven migration; confirm current service and new payment terms.

Full price details

Current Harper-branded service and medication quote unknown after the announced migration; earlier listing: $196/mo

Current availability
Current Harper-branded enrollment and coverage unconfirmed after the announced Blue Haven Rx migration
Prescription offer
Current prescription offer unconfirmed
AvailabilityPrescription availability unconfirmed— Harper announced an October 31, 2026 migration/account deadline. Current Harper enrollment, prices and patient continuity remain unconfirmed; earlier $149/$196 observations are historical.

Harper Meds in depth

Harper announced a migration, with a deadline now past

Harper Meds’ official homepage says it has joined Blue Haven Rx and that Harper accounts would close on October 31, 2026. The same notice remained online when checked in November. It confirms the announced migration and deadline, but does not establish whether every account closed or whether an individual patient’s care and records successfully transferred.

The notice also advertised a one-time discount on a first Blue Haven monthly order through October 31. That deadline has passed, so it should not be treated as a current offer. Existing patients should confirm their prescription, remaining medication and access to records through established support contacts before assuming another refill or a completed transfer.

Prices and patient arrangements do not transfer by assumption

Our earlier Harper observations were $149 per month for semaglutide and $196 for tirzepatide, checked in July 2026. They are historical, rather than current quotes for Harper or Blue Haven. Obtain a new itemized payment and supplied quantity before using the billing guide to compare continuing care. A migration notice does not preserve the old price automatically.

Harper’s privacy policy identifies Nexus Health Solutions LLC and affiliates, while Blue Haven’s current legal pages identify Eternum Health LLC. The notice does not explain the transaction’s legal structure or guarantee prescription, pharmacy, credit or record continuity. Confirm the current clinician and dispensing pharmacy; the pharmacy checklist provides useful questions without assuming an unchanged treatment arrangement.

Check old and new renewal arrangements separately

Harper’s older terms describe recurring membership billing, but their program details include testosterone services and do not establish every GLP-1 patient’s current agreement. Ask whether any old payment authorization remains active and how unused prepaid care is handled. The account deadline alone is not confirmation that a recurring charge was canceled or that a credit moved to the new service.

Blue Haven’s terms describe automatic renewal that can occur up to ten days before a paid term ends, with cancellation required at least forty-eight hours before that renewal date. Paid membership fees are generally nonrefundable. Before beginning a new plan, confirm its actual next-charge date and use the refund checklist to separate the new commitment from unresolved Harper payments.

Sources we checked

Public program pages and terms, checked November 2026. We have not enrolled in treatment or independently tested the medication.

This source update covers the review text and stated program terms. The existing numerical score has not been recalculated from this check; it should not be read as a new validation of every score factor.

Historical score

Retained from the earlier program listing; this score does not rate current prescription availability. See the methodology.

Price Stability78/100
Supply Reliability78/100
Transparency72/100
Access Breadth50/100
Clinical Oversight82/100
Track Record51/100

What the sources establish

  • Official Harper notice identifies the intended successor
  • Legacy and successor public policies remain accessible
  • The notice provides a support contact for continuity questions

What still needs checking

  • Actual account closure and transfer completion are unconfirmed
  • Historical Harper prices are not current Blue Haven quotes
  • Old subscriptions, prepaid credits and records need individual confirmation

The brief

Useful for: Existing Harper patients checking their account, prescription and payment arrangements after the announced migration. Harper Meds announced a move to Blue Haven Rx with an October 31 account deadline; current Harper enrollment and existing-patient continuity need confirmation.

The score above is a historical assessment of the earlier listing, not a recommendation for current treatment. Compare current provider information before choosing care.

Before you decide

The questions readers ask next after reading about Harper Meds.

Closest here

Directory neighbors by retained score; a status assessment does not establish current prescription availability.

Weighing Harper Meds against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs Harper Meds, and every provider that outranks it is listed on the Harper Meds alternatives ranking.

More providers we track (24)

514 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect Harper Meds's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Harper Meds's site. Not medical advice; see our disclosure.

← Back to all rankings